@FierceBiotech: Actelion drug macitentan flunks PhII but safety data bolsters confidence in blockbuster PhIII. News | Follow@FierceBiotech
@JohnCFierce: The Guardian runs down a litany of biotech failures, challenges and ends on a quick 'up' note regarding collaborations.Piece | Follow @JohnCFierce
@RyanMFierce: New facebook app "PiggyDemic," from scientists at Tel Aviv University, aims to simulate how viruses spread and mutate.Item | Follow @RyanMFierce
@MaureenFierce: Adimab adds Novo, Biogen Idec to roster of antibody partners. Story | Follow @MaureenFierce
> Valeant Pharmaceuticals has emerged as a white knight for Afexa, bidding $76 million for the company, which is fending off a hostile takeover attempt by Paladin. Story
> Gedeon Richter and STADA Arzneimittel AG have agreed to collaborate on developing a pair of biosimilars for rituximab and trastuzumab. Report
> AEterna Zentaris says that a late-stage study provided promising results for its oral diagnostic test for adult growth hormone deficiency. Story
> Contract Pharmaceuticals in Buffalo is letting go 128 workers. Story
Pharma News
@FiercePharma: Top drugmakers report payments of $150M to 165K docs so far this year, FT finds. Last full year: $437M. Report | Follow@FiercePharma
> FT: Pharma payments to U.S. docs hit $150M. Report
> Public Citizen: FDA should change generics labeling rules. Article
> ESC backs AZ drug over Plavix on mortality benefit. News
> Docs blame reimbursement, complexity, cost-benefit for Provenge uptake. Story
Biotech Research News
> JHU researchers have a full platelet of blood-clotting research. More
> Researchers find new clues into spread of influenza B. News
> A possible solution found for TTR-related amyloid diseases. Report
> So, a needle-pulling-thread is outdated, doc goes sutureless. Article
> Patient in stem-cell treatment for MS reports improvement. Details
> Researchers dream up a new cause for narcolepsy. Story
Manufacturing News
> Sabotage suspected in U.K. painkiller case. News
> Distributor plans to excise supply chain links. Story
> WHO committee report keeps pharma current. Brief
> Abbott taps manufacturing smarts in Haiti rebuild. Details
> Venus warning letter belies poor 483 response. Article
> Time to put the innovation into manufacturing. More
> U.S. tax reform or not, offshore beckons. Report
And Finally... A U.N. group is warning of a possible resurgence of bird flu after a mutant strain was spotted in Asia. Currently used vaccines evidently can't protect people from this new version of avian flu. Story